Eascra Biotech: Funding, Investors & Team (Sep 2026)
Eascra Biotech develops Janus-based nanomaterials using DNA nanotechnology that are highly efficient and very compatible with the body for treating conditions such as articular cartilage issues, central nervous system disorders, solid tumors, and other chronic illnesses. These nanotubes, inspired by DNA, are cost-effective, scalable, and offer a customizable solution for enhancing the effectiveness of drug treatments across various medical conditions.
Eascra Biotech has raised $100k across 1 funding round on record, the most recent an undisclosed round of $100k announced in May 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eascra Biotech Company Profile and Key Stats
Latest funding round on record: May 2025.
Eascra Biotech Funding Rounds
Eascra Biotech Founders and Leadership Team
No contact details are on record for this team yet.
Eascra Biotech Funding Compared to Other Biotechnology Startups
Eascra Biotech's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eascra Biotech in Biotechnology and Boston
Companies Similar to Eascra Biotech
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Eascra Biotech Funding FAQs
What does Eascra Biotech do?
Eascra Biotech develops Janus-based nanomaterials using DNA nanotechnology that are highly efficient and very compatible with the body for treating conditions such as articular cartilage issues, central nervous system disorders, solid tumors, and other chronic illnesses. These nanotubes, inspired by DNA, are cost-effective, scalable, and offer a customizable solution for enhancing the effectiveness of drug treatments across various medical conditions.
How much funding has Eascra Biotech raised?
Eascra Biotech has raised $100k across 1 round on record. The most recent is an undisclosed round of $100k announced in May 2025.
When did Eascra Biotech last raise funding?
Eascra Biotech's most recent funding round on record is an undisclosed round of $100k, announced in May 2025.
Who founded Eascra Biotech?
FundedIQ lists Mari Snow (Founder) at Eascra Biotech.
Where is Eascra Biotech headquartered?
Eascra Biotech is based in Boston, Massachusetts, United States.
How many employees does Eascra Biotech have?
Eascra Biotech is in the 1-10 employee band.
How does Eascra Biotech's funding compare to other Biotechnology startups?
Eascra Biotech's latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Eascra Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eascra Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.